Reports of 5-ASA-associated pancreatitis from the FDA adverse event reporting databases

被引：0
|
作者：
Ruggieri, Alexander P.
Kanumalla, Anju
Watson, John F.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [21] Adverse events associated with acute pancreatitis caused by immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
    Tong, Lihua
    Yuan, Yanling
    He, Wanming
    Yang, Wen
    Pan, Xingxi
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [22] Adverse event profile of CGRP monoclonal antibodies: findings from the FDA adverse event reporting database
    Wang, Qi
    Liu, Jingfang
    Sun, Hao
    Dong, Yongfei
    Tan, Weiliang
    Tang, Zaixiang
    Jiang, Yiguo
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (01) : 107 - 117
  • [23] FDA Adverse Event Reports of Retinal Vascular Occlusions Associated with PDE5 Inhibitor Use
    Li, Albert
    Pomeranz, Howard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [24] Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
    Xiong, Xiaomei
    Zhang, Xiuwen
    Li, Xiaoxia
    Huang, Taomin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1447 - 1452
  • [25] Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System
    Yang, Luxuan
    Zhang, Wenyong
    Shen, Xiujuan
    Liu, Meiqin
    Wu, Meiying
    Xiao, Dan
    DRUG DISCOVERIES AND THERAPEUTICS, 2025,
  • [26] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [27] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    BMC Pharmacology and Toxicology, 24
  • [28] FDA Reports of Alopecia as an Adverse Event to Isotretinoin
    Tkachenko, Elizabeth
    Singer, Sean B.
    Sharma, Priyank
    Barbieri, John
    Mostaghimi, Arash
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (04) : 451 - 452
  • [29] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Zou, Shu-peng
    Yang, Hai-yun
    Ouyang, Meng-ling
    Cheng, Qian
    Shi, Xuan
    Sun, Ming-hui
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [30] Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
    Huang, Shulan
    Dong, Hanlin
    Luo, Dongqiang
    Jiang, Jiazhen
    Liu, Manting
    Wu, Jiayu
    Dou, Xiangyun
    Zhou, Siyuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
12345